Stay updated on CTA and Methylation in NSCLC Response to Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the CTA and Methylation in NSCLC Response to Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CTA and Methylation in NSCLC Response to Pembrolizumab Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A new revision tag labeled Revision: v3.5.5 appears, replacing the prior Revision: v3.5.4.
    Difference
    0.1%
    Check dated 2026-06-05T13:12:50.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.4, updating the revision label from the previous v3.5.3. This reflects a new entry in the page's revision history.
    Difference
    0.1%
    Check dated 2026-05-15T04:45:21.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The interface revision tag was updated from v3.5.2 to v3.5.3. This reflects a minor platform update with no changes to the study details presented on the page.
    Difference
    0.1%
    Check dated 2026-04-30T18:52:58.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Revision: v3.5.2 now appears on the page, replacing the previous Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T11:10:51.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Revision history updated: added Revision v3.5.0 and removed Revision v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-18T19:56:34.000Z thumbnail image
  8. Check
    115 days ago
    Change Detected
    Summary
    A new page revision label 'Revision: v3.4.2' is added, and an operating-status notice about government funding as well as the older 'Revision: v3.4.1' label are removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T05:32:51.000Z thumbnail image

Stay in the know with updates to CTA and Methylation in NSCLC Response to Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CTA and Methylation in NSCLC Response to Pembrolizumab Clinical Trial page.